BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 3755271)

  • 1. [Combined chemotherapy including platinum derivatives in the combined treatment of patients with stage-III to -IV ovarian cancer].
    Perevodchikova NI; Gorbunova VA; Grigorova TM; Kozachenko VP; Marenich AF
    Vestn Akad Med Nauk SSSR; 1986; (5):8-11. PubMed ID: 3755271
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D; Fountzilas G; Aravantinos G; Kalofonos C; Efstathiou H; Farmakis D; Skarlos D; Pavlidis N; Economopoulos T; Dimopoulos MA
    Gynecol Oncol; 2006 Aug; 102(2):285-91. PubMed ID: 16516283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy in clinical stage III cancer of the ovary. Use of 1 and 2 agents].
    Torres Lobatón A; García Baños J; Nieto Riande P; Flores López G; Martínez Macías R
    Ginecol Obstet Mex; 1986 Jan; 54():3-7. PubMed ID: 3699490
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of 2 different forms of chemotherapy on remission in patients with advanced ovarian cancer].
    Krommer K; Keller G; Csaba I; Garadnay B; Göcze P
    Zentralbl Gynakol; 1990; 112(17):1105-10. PubMed ID: 2264421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
    Del Campo JM; Felip E; Rubio D; Vidal R; Bermejo B; Colomer R; Zanon V
    Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
    Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase III study of carboplatin in ovarian cancer].
    Kato T; Nishimura H; Yamabe T; Terashima Y; Kasamatsu T; Hirabayashi K; Nishiya I; Yajima A; Takamizawa H; Tsutsui F
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2297-304. PubMed ID: 3044276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease.
    Ho CM; Huang YJ; Chen TC; Huang SH; Liu FS; Chang Chien CC; Yu MH; Mao TL; Wang TY; Hsieh CY
    Gynecol Oncol; 2004 Jul; 94(1):197-203. PubMed ID: 15262142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An evaluation of two postoperative chemotherapy protocols in ovarian common epithelial cancer: a comparison of continuous and intermittent hospitalization].
    Sakamoto H; Suzuki H; Hayakawa S; Kiseki Y; Miyakawa Y; Ohkubo Y; Watanabe Y; Takami M; Kashiwazaki K; Tanaka H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1491-4. PubMed ID: 2584826
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the renal function in patients with ovarian carcinoma subjected to polychemotherapy including cisplatin or carboplatin].
    Gadducci A; Facchini V; Dell'Arciprete T; Del Bravo B; Galigani P; Palla R; Fioretti P
    Minerva Ginecol; 1988 Jan; 40(1):33-8. PubMed ID: 3287233
    [No Abstract]   [Full Text] [Related]  

  • 13. Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients.
    Rocconi RP; Straughn JM; Leath CA; Kilgore LC; Huh WK; Barnes MN; Partridge EE; Alvarez RD
    Oncologist; 2006 Apr; 11(4):336-41. PubMed ID: 16614229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor chemotherapy of ovarian cancer patients in advanced age].
    Behling H; Schirmer A; Krafft W; Brückmann D
    Zentralbl Gynakol; 1988; 110(2):95-101. PubMed ID: 3364065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of platinum dose intensity in treatment of epithelial ovarian cancer. Austrian Study Group for Therapy of Ovarian Cancer].
    Sevelda P; Kurz C; Obermair A; Vavra N; Breitenecker G; Czerwenka K; Dittrich C; Salzer H
    Wien Klin Wochenschr; 1993; 105(24):732-6. PubMed ID: 8116312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cisplatin (platidiam) and the prospects for using complex platinum compounds in the clinical chemotherapy of malignant tumors].
    Gorbunova VA
    Vopr Onkol; 1989; 35(3):325-30. PubMed ID: 2705315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of 28 years of treating advanced ovarian cancer.
    Krommer CF; Szalai JP
    Anticancer Res; 1993; 13(3):817-25. PubMed ID: 8317918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
    Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY
    Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
    Morgan RJ; Braly P; Cecchi G; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Parker P; Stein A; Cho J; Smith E; Coluzzi P; Najera L; Johnson D; Womack E; Doroshow JH
    Gynecol Oncol; 1999 Dec; 75(3):419-26. PubMed ID: 10600300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
    Pasmantier MW; Coleman M; Silver RT; Ballard WP
    Cancer Treat Rep; 1985 Jun; 69(6):689-93. PubMed ID: 3926310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.